Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported outcomes and measures applied in individuals undergoing colonoscopy surveillance for colorectal cancer: a scoping review.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative-intent treatment.

Clinical and translational medicine·2026
Same author

Geographical Disparities in Faecal Immunochemical Test-Based Colorectal Cancer Screening Participation and Positivity Rates: A Systematic Review and Meta-Analysis.

Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals·2026
Same author

Sociodemographic Drivers of Delays in Seeking Medical Care in the All of Us Cohort.

Nursing reports (Pavia, Italy)·2026
Same author

Cross-Ancestry Polygenic Prediction: Comparing Methods and Assessing Transferability Across Traits.

Genetic epidemiology·2026
Same author

Working together: pitches for international collaboration in women's health research from ISPOG 2025.

Journal of psychosomatic obstetrics and gynaecology·2025

Related Experiment Video

Updated: Jun 2, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early

Hossein Haji Ali Afzali1, Ecushla Linedale1,2,3, Craig Martin4

  • 1School of Public Health, Adelaide University, Adelaide, Australia.

Clinicoeconomics and Outcomes Research : CEOR
|June 1, 2026
PubMed
Summary
This summary is machine-generated.

Routine omega-3 testing and supplementation in early pregnancy can significantly reduce early preterm births. This strategy is cost-effective, preventing hundreds of births and saving millions in healthcare costs.

Keywords:
antenatal screeningcost-effectivenesshealth economicsmaternal nutritionomega-3 supplementationpregnancy carepreterm birth prevention

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

Area of Science:

  • Obstetrics and Gynecology
  • Nutritional Science
  • Health Economics

Background:

  • Preterm birth is a major global health concern, leading to infant mortality and long-term health issues.
  • Omega-3 supplementation in early pregnancy can lower the risk of preterm birth, especially early preterm birth (<34 weeks).
  • The economic impact of integrating omega-3 testing and supplementation into Australian antenatal care is not well understood.

Purpose of the Study:

  • To evaluate the cost-effectiveness of routine omega-3 testing and targeted supplementation versus current practices in Australia.
  • To model the potential reduction in early preterm births and associated healthcare cost savings.

Main Methods:

  • A decision analytic model was developed using Australian data on epidemiology, clinical outcomes, and costs.
  • The model projected outcomes over an 18-year period.
  • Sensitivity analyses were performed to assess the impact of uncertainties in key model parameters.

Main Results:

  • An estimated 17.5% of nearly 290,000 singleton pregnancies in 2022 were eligible for omega-3 supplementation.
  • The model predicted that omega-3 testing and supplementation would prevent 640 early preterm births.
  • This strategy was projected to save $26.1 million in direct healthcare costs, demonstrating a dominant economic advantage.

Conclusions:

  • Omega-3 testing and targeted supplementation present a scalable, cost-effective approach to reducing early preterm birth.
  • The strategy offers significant health benefits for mothers and infants, alongside economic advantages for the healthcare system.
  • The modeled cost savings are robust, supporting the national implementation of this intervention.